Department of Immunology and Microbial Sciences, Scripps Research Institute, La Jolla, CA 92037, USA.
J Immunol. 2009 Dec 15;183(12):7949-57. doi: 10.4049/jimmunol.0902493.
Direct identification and isolation of Ag-specific T cells became possible with the development of MHC tetramers, based on fluorescent avidins displaying biotinylated peptide-MHC complexes. This approach, extensively used for MHC class I-restricted T cells, has met very limited success with class II peptide-MHC complex tetramers (pMHCT-2) for the detection of CD4(+)-specific T cells. In addition, a very large number of these reagents, although capable of specifically activating T cells after being coated on solid support, is still unable to stain. To try to understand this puzzle and design usable tetramers, we examined each parameter critical for the production of pMHCT-2 using the I-A(d)-OVA system as a model. Through this process, the geometry of peptide-MHC display by avidin tetramers was examined, as well as the stability of rMHC molecules. However, we discovered that the most important factor limiting the reactivity of pMHCT-2 was the display of peptides. Indeed, long peptides, as presented by MHC class II molecules, can be bound to I-A/HLA-DQ molecules in more than one register, as suggested by structural studies. This mode of anchorless peptide binding allows the selection of a broader repertoire on single peptides and should favor anti-infectious immune responses. Thus, beyond the technical improvements that we propose, the redesign of pMHCT-2 will give us the tools to evaluate the real size of the CD4 T cell repertoire and help us in the production and testing of new vaccines.
直接鉴定和分离 Ag 特异性 T 细胞成为可能,其基础是 MHC 四聚体的发展,该四聚体基于显示生物素化肽-MHC 复合物的荧光亲和素。这种方法广泛用于 MHC Ⅰ类限制性 T 细胞,对于检测 CD4(+)特异性 T 细胞的 II 类肽-MHC 复合物四聚体(pMHCT-2),仅取得了非常有限的成功。此外,尽管大量的这些试剂在涂覆于固体支持物后能够特异性地激活 T 细胞,但仍然无法染色。为了试图理解这个难题并设计可用的四聚体,我们使用 I-A(d)-OVA 系统作为模型,检查了生产 pMHCT-2 的每个关键参数。通过这个过程,检查了亲和素四聚体展示肽-MHC 的几何形状,以及 rMHC 分子的稳定性。然而,我们发现限制 pMHCT-2 反应性的最重要因素是肽的展示。事实上,如结构研究所示,长肽,如 MHC Ⅱ类分子所呈现的肽,可以以不止一种方式结合到 I-A/HLA-DQ 分子上。这种无锚定肽结合模式允许在单个肽上选择更广泛的 repertoire,并且应该有利于抗感染免疫反应。因此,除了我们提出的技术改进之外,pMHCT-2 的重新设计将为我们提供评估 CD4 T 细胞 repertoire 实际大小的工具,并帮助我们生产和测试新疫苗。